These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 13400880)
1. Increase in tolerated dose of isoniazid in mice by use of cycloserine. JAMES WD; KAUFFMANN G; PRESCOTT B Proc Soc Exp Biol Med; 1957 Jan; 94(1):94-6. PubMed ID: 13400880 [No Abstract] [Full Text] [Related]
2. Spectrophotometric determination of cycloserine and isoniazid in pharmaceutical preparations. WOODSIDE JM; PIPER I; LEARY JB J Am Pharm Assoc Am Pharm Assoc; 1957 Dec; 46(12):729-31. PubMed ID: 13491492 [No Abstract] [Full Text] [Related]
3. Report on the use of isoniazid and cycloserine in 84 cases of pulmonary tuberculosis. BACHMAN H; FREUND J Am Rev Tuberc; 1959 Jan; 79(1):87-9. PubMed ID: 13606341 [No Abstract] [Full Text] [Related]
5. Cycloserine-isoniazid in the ambulatory treatment of active tuberculosis after failure of previous chemotherapy. LEITES V Am Rev Respir Dis; 1959 Jul; 80(1, Part 1):89-94. PubMed ID: 13670395 [No Abstract] [Full Text] [Related]
6. Cycloserine combined with other antituberculous agents in the treatment of pulmonary tuberculosis. EPSTEIN IG; NAIR KG; BOYD LJ Am Rev Tuberc; 1957 Apr; 75(4):553-75. PubMed ID: 13411412 [No Abstract] [Full Text] [Related]
7. Mechanisms of action of antibiotics. II. Studies on the modes of action of cycloserine and its L-stereoisomer. CIAK J; HAHN FE Antibiot Chemother (Northfield); 1959 Jan; 9(1):47-54. PubMed ID: 24545127 [No Abstract] [Full Text] [Related]
8. Effects of cycloserine on Mycobacterium tuberculosis in vitro. CUMMINGS MM; PATNODE RA; HUDGINS PC Antibiot Chemother (Northfield); 1955 Apr; 5(4):198-203. PubMed ID: 24543466 [No Abstract] [Full Text] [Related]
9. Cycloserine: antituberculous activity in vitro and in the experimental animal. STEENKEN W; WOLINSKY E Am Rev Tuberc; 1956 Apr; 73(4):539-46. PubMed ID: 13302684 [No Abstract] [Full Text] [Related]
10. [NEURO-PSYCHIATRIC COMPLICATIONS DUE TO ANTI-BACTERIAL DRUGS]. THIBAULT H; ROBERT D Clinique (Paris); 1963 Oct; 58():619-21. PubMed ID: 14092606 [No Abstract] [Full Text] [Related]
11. Synthesis of L-4-amino-3-isoxazolidinone, the unnatural stereoisomer of cycloserine and its antibiotic activity. SMRT J; BERANEK J; SICHER J; SKODA J; HESS VF; SORM F Experientia; 1957 Jul; 13(7):291. PubMed ID: 13461859 [No Abstract] [Full Text] [Related]
12. [On the possible anti-mitotic action of cycloserine and kanamycin. Experimental research]. MONCALVO F; GIORDANO M; MOREO GC; RONDANELLI R G Ital Tuberc Mal Torace; 1960; 14():15-22. PubMed ID: 14423506 [No Abstract] [Full Text] [Related]
13. [Effect of dl-cycloserine on the nervous system]. CHERNUKH AM Antibiotiki (Mosc); 1959; 4(2):73-7. PubMed ID: 24545298 [No Abstract] [Full Text] [Related]
14. The in vitro action of cycloserine on M. tuberculosis. BARCLAY WR; RUSSE H Am Rev Tuberc; 1955 Aug; 72(2):236-41. PubMed ID: 13238785 [No Abstract] [Full Text] [Related]
15. [PSYCHIC DISORDERS DUE TO ANTITUBERCULAR ANTIBIOTICS]. POROT M; GIRARD J Fr Med; 1964 Jan; 27():19-27. PubMed ID: 14135343 [No Abstract] [Full Text] [Related]
16. Toxicity and pharmacology of cycloserine. MASON RC; ROBINSON HJ; SIEGEL H Am Rev Tuberc; 1956 Dec; 74(6):972-6. PubMed ID: 13372984 [No Abstract] [Full Text] [Related]
17. Cycloserine alone and in combination with other drugs in experimental guinea pig tuberculosis. WOLINSKY E; STEENKEN W Am Rev Tuberc; 1957 Mar; 75(3):510-3. PubMed ID: 13403181 [No Abstract] [Full Text] [Related]